Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9674)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang YH, Cao YF, Jiang ZY, Zhang S, Gao F. Th22 cell accumulation is associated with colorectal cancer development. World J Gastroenterol 2015; 21(14): 4216-4224 [PMID: PMC4394082 DOI: 10.3748/wjg.v21.i14.4216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4216.htm |
| Number | Citing Articles |
| 1 |
Jeremy Goc, Matthew R. Hepworth, Gregory F. Sonnenberg. Group 3 innate lymphoid cells: regulating host–commensal bacteria interactions in inflammation and cancer. International Immunology 2016; 28(1): 43 doi: 10.1093/intimm/dxv056
|
| 2 |
Nisha Nagarsheth, Max S. Wicha, Weiping Zou. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews Immunology 2017; 17(9): 559 doi: 10.1038/nri.2017.49
|
| 3 |
Florian Guisier, Mateus Camargo Barros-Filho, Leigha D. Rock, Megan Strachan-Whaley, Erin A. Marshall, Graham Dellaire, Wan L. Lam. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1224: 35 doi: 10.1007/978-3-030-35723-8_3
|
| 4 |
Hufei Wang, Kangjia Luo, Zilong Guan, Zhi Li, Jun Xiang, Suwen Ou, Yangbao Tao, Songlin Ran, Jinhua Ye, Tianyi Ma, Tianyu Qiao, Zhiming Zhang, Yinghu Jin, Yanni Song, Rui Huang. Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.811900
|
| 5 |
Xuehua Chen, Yanfu Wang, Jiali Wang, Jinhui Wen, Xuzhao Jia, Xiaojun Wang, Hua Zhang. Accumulation of T‑helper 22 cells, interleukin‑22 and myeloid‑derived suppressor cells promotes gastric cancer progression in elderly patients. Oncology Letters 2018; doi: 10.3892/ol.2018.8612
|
| 6 |
Guanglin Cui. TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01002
|
| 7 |
Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, Ephraim A. Ansa-Addo, Jose Roberto Kfoury Junior. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_332
|
| 8 |
Soheil Tavakolpour, Mohammad Darvishi. Cancer Immunology. 2020; : 63 doi: 10.1007/978-3-030-30845-2_5
|
| 9 |
Shannon M. Liudahl, Lisa M. Coussens. Immunology. 2018; : 97 doi: 10.1016/B978-0-12-809819-6.00008-3
|
| 10 |
S. Haleh Hosseini, Nadia Sharafkandi, Narges Seyfizadeh, Maryam Hemmatzadeh, Faroogh Marofi, Navid Shomali, Mohammad Karimi, Hamed Mohammadi. Progression or suppression: Two sides of the innate lymphoid cells in cancer. Journal of Cellular Biochemistry 2020; 121(4): 2739 doi: 10.1002/jcb.29503
|
| 11 |
Hassan Doulabi, Elham Masoumi, Maryam Rastin, Afsaneh Foolady Azarnaminy, Seyed-Alireza Esmaeili, Mahmoud Mahmoudi. The role of Th22 cells, from tissue repair to cancer progression. Cytokine 2022; 149: 155749 doi: 10.1016/j.cyto.2021.155749
|
| 12 |
Jia Zhang, Zhou Liu, Lingpeng Liu, Mingwen Huang, Yong Huang. Th22/IL-22 mediates the progression of HBV-related hepatocellular carcinoma via STAT3. Cytotechnology 2022; 74(2): 203 doi: 10.1007/s10616-021-00517-9
|
| 13 |
Soheil Tavakolpour, Fatemeh Karami. Cancer Immunology. 2021; : 465 doi: 10.1007/978-3-030-50287-4_26
|
| 14 |
Lukas F. Mager, Marie-Hélène Wasmer, Tilman T. Rau, Philippe Krebs. Cytokine-Induced Modulation of Colorectal Cancer. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00096
|
| 15 |
Jöran Lücke, Ahmad Mustafa Shiri, Tao Zhang, Jan Kempski, Anastasios D. Giannou, Samuel Huber. Rationalizing heptadecaphobia: TH17 cells and associated cytokines in cancer and metastasis. The FEBS Journal 2021; 288(24): 6942 doi: 10.1111/febs.15711
|
| 16 |
Yu Chen, Maud Vandereyken, Ian P. Newton, Ignacio Moraga, Inke S. Näthke, Mahima Swamy, Connie J. Eaves. Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22. PLOS Biology 2019; 17(11): e3000540 doi: 10.1371/journal.pbio.3000540
|
| 17 |
Blanca E. Callejas, Graham A. D. Blyth, Nicholas Jendzjowsky, Arthur Wang, Anshu Babbar, Konstantin Koro, Richard J. A. Wilson, Margaret M. Kelly, Eduardo R. Cobo, Derek M. McKay. Interleukin-4 Programmed Macrophages Suppress Colitis and Do Not Enhance Infectious-Colitis, Inflammation-Associated Colon Cancer or Airway Hypersensitivity. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.744738
|
| 18 |
Jiuheng Yin, Baifa Sheng, Yuan Qiu, Kunqiu Yang, Weidong Xiao, Hua Yang. Role of AhR in positive regulation of cell proliferation and survival. Cell Proliferation 2016; 49(5): 554 doi: 10.1111/cpr.12282
|
| 19 |
Pranav Seth, Shweta Dubey. IL-22 as a target for therapeutic intervention: Current knowledge on its role in various diseases. Cytokine 2023; 169: 156293 doi: 10.1016/j.cyto.2023.156293
|
| 20 |
U. M. Zissler, J. Esser-von Bieren, C. A. Jakwerth, A. M. Chaker, C. B. Schmidt-Weber. Current and future biomarkers in allergic asthma. Allergy 2016; 71(4): 475 doi: 10.1111/all.12828
|
| 21 |
Hassan Doulabi, Maryam Rastin, Hossein Shabahangh, Ghodratollah Maddah, Abbas Abdollahi, Reza Nosratabadi, Seyed-Alireza Esmaeili, Mahmoud Mahmoudi. Analysis of Th22, Th17 and CD4+cells co-producing IL-17/IL-22 at different stages of human colon cancer. Biomedicine & Pharmacotherapy 2018; 103: 1101 doi: 10.1016/j.biopha.2018.04.147
|
| 22 |
Pedro Hernandez, Konrad Gronke, Andreas Diefenbach. A catch‐22: Interleukin‐22 and cancer. European Journal of Immunology 2018; 48(1): 15 doi: 10.1002/eji.201747183
|
| 23 |
Minkyo Song, Shizuka Sasazuki, M. Constanza Camargo, Taichi Shimazu, Hadrien Charvat, Taiki Yamaji, Norie Sawada, Troy J. Kemp, Ruth M. Pfeiffer, Allan Hildesheim, Ligia A. Pinto, Charles S. Rabkin, Shoichiro Tsugane. Circulating inflammatory markers and colorectal cancer risk: A prospective case‐cohort study in Japan. International Journal of Cancer 2018; 143(11): 2767 doi: 10.1002/ijc.31821
|
| 24 |
Steven F. Gameiro, Farhad Ghasemi, John W. Barrett, James Koropatnick, Anthony C. Nichols, Joe S. Mymryk, Saman Maleki Vareki. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Methods in Enzymology 2020; 636: 49 doi: 10.1016/bs.mie.2019.05.040
|
| 25 |
Miguel Martínez-Rodríguez, Carlos Monteagudo. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2021; 1302: 113 doi: 10.1007/978-3-030-62658-7_9
|
| 26 |
Sheng-Nan Jia, Ying-Bo Han, Rui Yang, Ze-Cheng Yang. Chemokines in colon cancer progression. Seminars in Cancer Biology 2022; 86: 400 doi: 10.1016/j.semcancer.2022.02.007
|
| 27 |
Noha Mousaad Elemam, Azzam A. Maghazachi. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_26-1
|
| 28 |
Xun Che, Wei Dai. Aryl Hydrocarbon Receptor: Its Regulation and Roles in Transformation and Tumorigenesis. Current Drug Targets 2019; 20(6): 625 doi: 10.2174/1389450120666181109092225
|
| 29 |
Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, Awal Ayaz Khan, Galal Yahya, Simona Cavalu. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. Journal of Clinical Medicine 2023; 12(9): 3127 doi: 10.3390/jcm12093127
|
| 30 |
Susan Costantini, Elena Di Gennaro, Francesca Capone, Alfonso De Stefano, Guglielmo Nasti, Carlo Vitagliano, Sergio Venanzio Setola, Fabiana Tatangelo, Paolo Delrio, Francesco Izzo, Antonio Avallone, Alfredo Budillon. Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1110104
|
| 31 |
Carsten B. Schmidt-Weber. Implementing Precision Medicine in Best Practices of Chronic Airway Diseases. 2019; : 91 doi: 10.1016/B978-0-12-813471-9.00008-6
|
| 32 |
Sonia A.M. Ferkel, Elizabeth A. Holman, Raoul S. Sojwal, Samuel J.S. Rubin, Stephan Rogalla. Tumor-Infiltrating Immune Cells in Colorectal Cancer. Neoplasia 2025; 59: 101091 doi: 10.1016/j.neo.2024.101091
|
| 33 |
Mirna Perusina Lanfranca, Yanwei Lin, Jingyuan Fang, Weiping Zou, Timothy Frankel. Biological and pathological activities of interleukin-22. Journal of Molecular Medicine 2016; 94(5): 523 doi: 10.1007/s00109-016-1391-6
|
| 34 |
Joseph W. Dean, Liang Zhou. Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity. Trends in Immunology 2022; 43(3): 245 doi: 10.1016/j.it.2022.01.008
|
| 35 |
Xian‑Wen Yang, Hai‑Xing Jiang, Ronge Lei, Wei‑Shun Lu, Shi‑Hui Tan, Shan‑Yu Qin. Recruitment and significance of Th22 cells and Th17 cells in malignant ascites. Oncology Letters 2018; doi: 10.3892/ol.2018.9316
|
| 36 |
Jan Korbecki, Szymon Grochans, Izabela Gutowska, Katarzyna Barczak, Irena Baranowska-Bosiacka. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. International Journal of Molecular Sciences 2020; 21(20): 7619 doi: 10.3390/ijms21207619
|
| 37 |
Nikoo Hossein‐Khannazer, Zeineb Zian, Joaira Bakkach, Ali N. Kamali, Ramin Hosseinzadeh, Abubakar Umar Anka, Reza Yazdani, Gholamreza Azizi. Features and roles of T helper 22 cells in immunological diseases and malignancies. Scandinavian Journal of Immunology 2021; 93(5) doi: 10.1111/sji.13030
|
| 38 |
Peiying Wang, Wing Keung Chan, Jiming Wang, Zhouxin Yang, Youwei Wang. Role of IL-22 in intestinal microenvironment and potential targeted therapy through diet. Immunologic Research 2023; 71(2): 121 doi: 10.1007/s12026-022-09325-5
|
| 39 |
Qi Jiang, Guocan Yang, Fan Xiao, Jue Xie, Shengjun Wang, Liwei Lu, Dawei Cui. Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.688066
|
| 40 |
Mingli Yue, Meng-Meng Chen, Bingqiang Zhang, Yin Wang, Peifeng Li, Yi Zhao. The functional roles of chemokines and chemokine receptors in colorectal cancer progression. Biomedicine & Pharmacotherapy 2024; 170: 116040 doi: 10.1016/j.biopha.2023.116040
|
| 41 |
Xu Wang, Shixin Chan, Jiajie Chen, Yuanmin Xu, Longfei Dai, Qijun Han, Zhenglin Wang, Xiaomin Zuo, Yang Yang, Hu Zhao, Ming Wang, Chen Wang, Zichen Li, Huabing Zhang, Wei Chen. Robust machine−learning based prognostic index using cytotoxic T lymphocyte evasion genes highlights potential therapeutic targets in colorectal cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03239-y
|
| 42 |
Danfeng Sun, Yanwei Lin, Jie Hong, Haoyan Chen, Nisha Nagarsheth, Dongjun Peng, Shuang Wei, Emina Huang, Jingyuan Fang, Ilona Kryczek, Weiping Zou. Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling. OncoImmunology 2016; 5(8): e1082704 doi: 10.1080/2162402X.2015.1082704
|
| 43 |
Beilei Wu, Lijun Tao, Daqing Yang, Wei Li, Hongbo Xu, Qianggui He, Shijia Zhu. Development of an Immune Infiltration‐Related Eight‐Gene Prognostic Signature in Colorectal Cancer Microenvironment. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/2719739
|
| 44 |
Anastasios D. Giannou, Jöran Lücke, Dörte Kleinschmidt, Ahmad Mustafa Shiri, Babett Steglich, Mikolaj Nawrocki, Tao Zhang, Dimitra E. Zazara, Jan Kempski, Lilan Zhao, Olympia Giannou, Theodora Agalioti, Leonie Brockmann, Franziska Bertram, Morsal Sabihi, Marius Böttcher, Florian Ewald, Kornelius Schulze, Johann von Felden, Andres Machicote, Ioannis C. Maroulis, Petra C. Arck, Julia-Kristin Graß, Baris Mercanoglu, Matthias Reeh, Stefan Wolter, Michael Tachezy, Hannes Seese, Myrto Theodorakopoulou, Panagis M. Lykoudis, Asmus Heumann, Faik G. Uzunoglu, Tarik Ghadban, Oliver Mann, Jakob R. Izbicki, Jun Li, Anna Duprée, Nathaniel Melling, Nicola Gagliani, Samuel Huber. A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma. Cancers 2022; 14(24): 6019 doi: 10.3390/cancers14246019
|
| 45 |
Varun Sasidharan Nair, Reem Saleh, Rowaida Z Taha, Salman M Toor, Khaled Murshed, Ayman A Ahmed, Mohamed A Kurer, Mohamed Abu Nada, Fares Al Ejeh, Eyad Elkord.
Differential gene expression of tumor-infiltrating CD4
+
T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1825178
|
| 46 |
Martina Karasová, Jiřina Procházková, Zuzana Tylichová, Radek Fedr, Miroslav Ciganek, Miroslav Machala, Zdeněk Dvořák, Barbora Vyhlídalová, Iveta Zůvalová, Jiří Ehrmann, Jan Bouchal, Zdeněk Andrysík, Jan Vondráček. Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells. Cancers 2022; 14(17): 4245 doi: 10.3390/cancers14174245
|
| 47 |
Saleh Y Alabbas, Jakob Begun, Timothy H Florin, Iulia Oancea. The role of IL‐22 in the resolution of sterile and nonsterile inflammation. Clinical & Translational Immunology 2018; 7(4) doi: 10.1002/cti2.1017
|